Axillary dissection in the context of the biology of lymph node metastases
Identifieur interne : 004514 ( Istex/Curation ); précédent : 004513; suivant : 004515Axillary dissection in the context of the biology of lymph node metastases
Auteurs : James E. Gervasoni Jr. [États-Unis] ; Charu Taneja [États-Unis] ; Maureen A. Chung [États-Unis] ; Blake Cady [États-Unis]Source :
- The American Journal of Surgery [ 0002-9610 ] ; 2000.
Abstract
Background: Modern breast surgery, as the primary treatment of invasive breast carcinoma, has been evolving over the last century. Aggressive radical surgery, which included chest wall resection, complete axillary clearance and internal mammary node dissection, has slowly changed to a less aggressive approach. This has been based on an improved understanding of the biology of the disease. Over the years, randomized prospective trials, performed at centers all over the world, have demonstrated that axillary dissection does not impact on the overall survival while it helps with loco-regional control of breast cancer. Its major role, at the present time, is limited to staging and prognostication; functions that are equally well served by the limited approach of a sentinel node biopsy.Sources:This review is based on the available medical literature involving the biology and organ specificity of the metastatic process, not only in breast cancer but also in other malignancies. In addition, studies pertaining to clinical breast cancer, and the role of surgery in its treatment, were reviewed. The ongoing trials on the role of sentinel node biopsy in the management of the clinically node negative patients are discussed.Conclusions: This review covers the history, pathophysiology, and clinical basis of the current role of axillary dissection for invasive breast cancer. From the data presented we hope that the medical community will agree that there is no therapeutic role for extended axillary dissection at the current time.
Url:
DOI: 10.1016/S0002-9610(00)00455-4
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :004514
Links to Exploration step
ISTEX:92898FB28CACE4B750089A2502E3A81CE61F2D4ELe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Axillary dissection in the context of the biology of lymph node metastases</title><author><name sortKey="Gervasoni Jr, James E" sort="Gervasoni Jr, James E" uniqKey="Gervasoni Jr J" first="James E" last="Gervasoni Jr.">James E. Gervasoni Jr.</name><affiliation wicri:level="1"><mods:affiliation>Department of Surgical Oncology (JEG, CT), Roger Williams Hospital, Providence, Rhode Island, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Surgical Oncology (JEG, CT), Roger Williams Hospital, Providence, Rhode Island</wicri:regionArea></affiliation></author><author><name sortKey="Taneja, Charu" sort="Taneja, Charu" uniqKey="Taneja C" first="Charu" last="Taneja">Charu Taneja</name><affiliation wicri:level="1"><mods:affiliation>Department of Surgical Oncology (JEG, CT), Roger Williams Hospital, Providence, Rhode Island, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Surgical Oncology (JEG, CT), Roger Williams Hospital, Providence, Rhode Island</wicri:regionArea></affiliation></author><author><name sortKey="Chung, Maureen A" sort="Chung, Maureen A" uniqKey="Chung M" first="Maureen A" last="Chung">Maureen A. Chung</name><affiliation wicri:level="1"><mods:affiliation>Boston University School of Medicine, Boston, Massachusetts, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Boston University School of Medicine, Boston, Massachusetts</wicri:regionArea></affiliation></author><author><name sortKey="Cady, Blake" sort="Cady, Blake" uniqKey="Cady B" first="Blake" last="Cady">Blake Cady</name><affiliation wicri:level="1"><mods:affiliation>Boston University School of Medicine, Boston, Massachusetts, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Boston University School of Medicine, Boston, Massachusetts</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:92898FB28CACE4B750089A2502E3A81CE61F2D4E</idno><date when="2000" year="2000">2000</date><idno type="doi">10.1016/S0002-9610(00)00455-4</idno><idno type="url">https://api.istex.fr/document/92898FB28CACE4B750089A2502E3A81CE61F2D4E/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">004514</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">004514</idno><idno type="wicri:Area/Istex/Curation">004514</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Axillary dissection in the context of the biology of lymph node metastases</title><author><name sortKey="Gervasoni Jr, James E" sort="Gervasoni Jr, James E" uniqKey="Gervasoni Jr J" first="James E" last="Gervasoni Jr.">James E. Gervasoni Jr.</name><affiliation wicri:level="1"><mods:affiliation>Department of Surgical Oncology (JEG, CT), Roger Williams Hospital, Providence, Rhode Island, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Surgical Oncology (JEG, CT), Roger Williams Hospital, Providence, Rhode Island</wicri:regionArea></affiliation></author><author><name sortKey="Taneja, Charu" sort="Taneja, Charu" uniqKey="Taneja C" first="Charu" last="Taneja">Charu Taneja</name><affiliation wicri:level="1"><mods:affiliation>Department of Surgical Oncology (JEG, CT), Roger Williams Hospital, Providence, Rhode Island, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Surgical Oncology (JEG, CT), Roger Williams Hospital, Providence, Rhode Island</wicri:regionArea></affiliation></author><author><name sortKey="Chung, Maureen A" sort="Chung, Maureen A" uniqKey="Chung M" first="Maureen A" last="Chung">Maureen A. Chung</name><affiliation wicri:level="1"><mods:affiliation>Boston University School of Medicine, Boston, Massachusetts, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Boston University School of Medicine, Boston, Massachusetts</wicri:regionArea></affiliation></author><author><name sortKey="Cady, Blake" sort="Cady, Blake" uniqKey="Cady B" first="Blake" last="Cady">Blake Cady</name><affiliation wicri:level="1"><mods:affiliation>Boston University School of Medicine, Boston, Massachusetts, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Boston University School of Medicine, Boston, Massachusetts</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">The American Journal of Surgery</title><title level="j" type="abbrev">AJS</title><idno type="ISSN">0002-9610</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="2000">2000</date><biblScope unit="volume">180</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="278">278</biblScope><biblScope unit="page" to="283">283</biblScope></imprint><idno type="ISSN">0002-9610</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0002-9610</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Background: Modern breast surgery, as the primary treatment of invasive breast carcinoma, has been evolving over the last century. Aggressive radical surgery, which included chest wall resection, complete axillary clearance and internal mammary node dissection, has slowly changed to a less aggressive approach. This has been based on an improved understanding of the biology of the disease. Over the years, randomized prospective trials, performed at centers all over the world, have demonstrated that axillary dissection does not impact on the overall survival while it helps with loco-regional control of breast cancer. Its major role, at the present time, is limited to staging and prognostication; functions that are equally well served by the limited approach of a sentinel node biopsy.Sources:This review is based on the available medical literature involving the biology and organ specificity of the metastatic process, not only in breast cancer but also in other malignancies. In addition, studies pertaining to clinical breast cancer, and the role of surgery in its treatment, were reviewed. The ongoing trials on the role of sentinel node biopsy in the management of the clinically node negative patients are discussed.Conclusions: This review covers the history, pathophysiology, and clinical basis of the current role of axillary dissection for invasive breast cancer. From the data presented we hope that the medical community will agree that there is no therapeutic role for extended axillary dissection at the current time.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004514 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 004514 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:92898FB28CACE4B750089A2502E3A81CE61F2D4E
|texte= Axillary dissection in the context of the biology of lymph node metastases
}}
| This area was generated with Dilib version V0.6.31. |  |